Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients

This is the first study to identify lipidomic markers in plasma associated with response of acutely ill schizophrenia patients in response to specific antipsychotic treatments. The study population included 54 schizophrenia patients treated with antipsychotics for 6 weeks. Treatment led to significa...

Full description

Bibliographic Details
Main Authors: Adriano Aquino, Guilherme L. Alexandrino, Paul C. Guest, Fabio Augusto, Alexandre F. Gomes, Michael Murgu, Johann Steiner, Daniel Martins-de-Souza
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Psychiatry
Subjects:
schizophrenia
drug response
antipsychotics
lipidomics
biomarkers
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2018.00209/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2018.00209/full

Similar Items